| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Dez―20 |
The experience of using succinate-containing crystalloid solution in the correction of COVID-19-associated endotheliopathy |
Olga V. Nikolaeva, Ionas S. Simutis, Vyacheslav A. Ratnikov, Alexey N. Scheglov, Larisa B. Gaykovaya, Tatyana P. Zavyalova |
| 2 |
[GO] |
2024―Nov―06 |
Features of acute coronary syndrome after a COVID-19 in the aspect of pulmonary hypertension |
Giorgi Dularidze, Sergey A. Saiganov, Igor N. Kochanov, Viktoriya V. Sklyarova, Taras Ya. Burak, Aleksandr L. Kaledin |
| 3 |
[GO] |
2024―Jul―03 |
Clinical cases of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA vasculitis) induced by COVID-19 |
Olga V. Mashkunova, Vadim I. Mazurov |
| 4 |
[GO] |
2024―Apr―26 |
Electrocardiographic signs of cardiovascular system dysfunction in the context of various courses of COVID-19 in young and middle-aged individuals |
Ekaterina S. Bratilova, Vasilii A. Kachnov, Vadim V. Tyrenko |
| 5 |
[GO] |
2024―Jan―13 |
The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies |
Anna Yu. Anisenkova, Vadim I. Mazurov, Svetlana V. Apalko, Oleg S. Popov, Natalya N. Sushentseva, Olga P. Mamaeva, et al. (+3) Sergei V. Mosenko, Andrey M. Sarana, Sergey G. Shcherbak |
| 6 |
[GO] |
2023―Dez―14 |
Percutaneous coronary intervention in patients admitted with acute coronary syndrome within 6 months after COVID-19 (retrospective single-center study) |
Giorgi Dularidze, Sergey A. Sayganov, Igor N. Kochanov, Viktoriya V. Sklyarova |
| 7 |
[GO] |
2023―Jul―28 |
Comparative analysis of the course of COVID-19 and post-COVID syndrome in patients with inflammatory bowel disease and COVID-19 caused by the Omicron strain and earlier strains |
Luciya M. Kupkenova, Alfiya Kh. Odintsova, Dilyara G. Iskhakova, Natalya A. Cheremina, Diana I. Abdulganieva |
| 8 |
[GO] |
2022―Nov―17 |
Clinical, laboratory and instrumental predictors of the effectiveness of anti-inflammatory therapy in COVID-19 |
Irina M. Sukhomlinova, Igor G. Bakulin, Maxim Yu. Kabanov |
| 9 |
[GO] |
2022―Nov―17 |
The role of redox status in platelet dysfunction in severe COVID-19-associated pneumonia |
Mikhail V. Osikov, Vladimir N. Antonov, Semen O. Zotov, Galina L. Ignatova |
| 10 |
[GO] |
2022―Nov―17 |
Problems associated with new coronavirus infection vaccination in patients with rheumatic diseases |
Vadim I. Mazurov, Evgeny L. Nasonov, Aleksander M. Lila, Inna Z. Gaydukova, Oksana V. Inamova, Natalia Yu. Leonchenkova |
| 11 |
[GO] |
2022―Jun―17 |
Anti-inflammatory therapy for COVID-19: effectiveness and predictors of response |
Irina M. Sukhomlinova, Igor G. Bakulin, Maxim Yu. Kabanov |
| 12 |
[GO] |
2022―Jun―17 |
Clinical and genetic predictors of cardiovascular events as the risk of an unfavorable course and outcomes of novel coronavirus infection |
Ekaterina S. Bratilova, Vasilii A. Kachnov, Vadim V. Tyrenko, Svetlana N. Kolyubaeva |
| 13 |
[GO] |
2022―Jun―17 |
Liver injury and novel coronavirus infection: development mechanisms and clinical manifestation |
Maria A. Livzan, Olga V. Gaus, Darya A. Gavrilenko |
| 14 |
[GO] |
2021―Aug―30 |
Impact of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases |
Vadim I. Mazurov, Irina B. Belyaeva, Lubov E. Sarantseva, Anton L. Chudinov, Roman A. Bashkinov, Evgeni A. Trofimov, et al. (+4) Olga A. Smulskaya, Oksana V. Inamova, Marianna S. Petrova, Evgeni S. Melnikov |
| 15 |
[GO] |
2021―Jun―08 |
Therapeutic potential of the stromal vascular fraction in COVID-19 |
Valentin N. Pavlov, Albert A. Kazikhinurov, Rustem A. Kazikhinurov, Murad A. Agaverdiyev, Ilgiz F. Gareev, Ozal A. Beylerli, Bakhodur Z. Mazorov |
| 16 |
[GO] |
2021―Jun―08 |
Prognostic value of cytokines in COVID-19 associated pneumonia |
Olga Yu. Tkachenko, Margarita Yu. Pervakova, Sergey V. Lapin, Aleksandra V. Mazing, Darya A. Kuznetsova, Anna N. Moshnikova, et al. (+16) Irina V. Kholopova, Tatyana V. Blinova, Elena A. Surkova, Aleksandr N. Kulikov, Evgeniy A. Vorobyev, Snezhana V. Vorobyeva, Oksana V. Stanevich, Yuriy S. Polushin, Irina V. Shlyk, Alexey Afanasyev, Elena G. Gavrilova, Olga N. Titova, Elizaveta V. Volchkova, Vsevolod G. Potapenko, Svetlana V. Khudonogova, Vadim I. Mazurov |
| 17 |
[GO] |
2021―Jun―08 |
Major predictive risk factors for cytokine storm in COVID-19 patients (Clinical trials) |
Anna Yu. Anisenkova, Svetlana V. Apalko, Zakhar P. Asaulenko, Aleksandr N. Bogdanov, Dmitriy A. Vologzhanin, Evgenii Yu. Garbuzov, et al. (+8) Aleksandr S. Golota, Tatyana A. Kamilova, Olga A. Klitsenko, Evdokiya M. Minina, Sergey V. Mosenko, Stanislav P. Urazov, Dmitriy N. Khobotnikov, Sergey G. Sherbak |
| 18 |
[GO] |
2021―Mrz―22 |
Possibilities of janus kinase inhibitors application in complex treatment of patients with COVID-19 |
Sergei A. Saiganov, Vadim I. Mazurov, Evgenii S. Melnikov, Elgudzha L. Latariia |
| 19 |
[GO] |
2020―Aug―22 |
Current, effectiveness of therapy and outcomes of new coronavirus infection: preliminary analysis |
Sergey A. Sayganov, Vadim I. Mazurov, Igor G. Bakulin, Elguja L. Lataria, S A Artyushkin, Olga Yu. Chizhova, et al. (+13) Irina A. Ruslyakova, Natalia A. Prokofieva, Tatiana S. Fil, Daridzhan B. Tsurtsumiya, Sergey V. Tikhonov, Mariya I. Skalinskaya, Irina A. Rasmagina, Marianna K. Alieva, E A Trofimov, Nataliay V. Bakulina, Elena V. Kolmakova, Anna D. Sheyko, Lia N. Belousova |
| 20 |
[GO] |
2020―Mai―29 |
Inflammatory bowel diseases during the coronavirus pandemic: potential risks and ways to reduce them |
Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva, Maria S. Zhuravleva |
|
